Canada · Delayed Price · Currency is CAD InnoCan Pharma Company Description
InnoCan Pharma Corporation, a pharmaceutical company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Poland, France, and internationally.
The company engages in the research and development of COVID-19 and other condition treatment by using CBD loaded exosomes; and CBD loaded liposomes.
Its product includes CBD eye serum, CBD face oil, CBD face cream, CBD facial serum, CBD sleeping mask, CBD recovery lotion, and the Relief & Go spray.
The company is also involved in the commercialization and sale of branded CBD integrated pharmaceutical and topical treatment products.
InnoCan Pharma Corporation was incorporated in 2018 and is headquartered in Calgary, Canada.
| Country | Canada |
| Founded | 2017 |
| Industry | Household & Personal Products |
| Sector | Consumer Staples |
| Employees | 5 |
| CEO | Iris Bincovich |
Contact Details
Address: 1015, 926 – 5 Avenue SW Calgary, AB AB Canada | |
| Phone | 403-777-1519 |
Stock Details
| Ticker Symbol | INNO |
| Exchange | Canadian Securities Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | CA45783P1027 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Roni Kamhi | Chief Operating Officer, Chief Executive Officer of B.I. Sky Global LTD and Director |
| Iris Bincovich | Chief Executive Officer and Interim Chairwoman |
| Nelson Harvey Halpern F.C.A., FCPA | Chief Financial Officer |
| Eyal Flom L.L.M., M.B.A. | Company Secretary, General Counsel and Director |
| Dr. Eyal Kalo | Vice President of Research and Development |